Injection of nerve growth factor into stellate ganglia improves norepinephrine reuptake into failing hearts

Hypertension

Volumn 47, Issue 2, 2006, Pages 209-215

  Kreusser, Michael M ^a   Haass, Markus ^b   Buss, Sebastian J ^a   Hardt, Stefan E ^a   Gerber, Stefan H ^a   Kinscherf, Ralf ^a   Katus, Hugo A ^a   Backs, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b St Hedwig Klinik GmbH   (Germany)

Author keywords

Heart failure; Neuroregulators; Norepinephrine; Sympathetic nervous system

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NORADRENALIN; NORADRENALIN TRANSPORTER; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART FAILURE; HEART PERFUSION; HOMEOSTASIS; MALE; NERVE GROWTH; NONHUMAN; NORADRENALIN UPTAKE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; STELLATE GANGLION; SYMPATHETIC NERVE; TREATMENT OUTCOME;

ANIMALS; ECHOCARDIOGRAPHY; HEART; HEART FAILURE, CONGESTIVE; INJECTIONS; MALE; MYOCARDIUM; NERVE ENDINGS; NERVE GROWTH FACTOR; NOREPINEPHRINE; RATS; RATS, WISTAR; STELLATE GANGLION; SYMPATHETIC NERVOUS SYSTEM;

EID: 31944441210     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000200157.25792.26     Document Type: Article

References (38)

1. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
2. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676.
3. Liang CS, Fan TH, Sullebarger JT, Sakamoto S. Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation. J Clin Invest. 1989;84:1267-1275.
4. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
5. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, Kübler W, Haass M. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol. 2001;33:461-472.
6. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136-1143.
7. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, Vatner SF, Vatner DE. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993;91:907-914.
8. Himura Y, Felten SY, Kashiki M, Lewandowski TJ, Delehanty JM, Liang CS. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation. 1993;88:1299-1309.
9. Kawai H, Mohan A, Hagen J, Dong E, Armstrong J, Stevens SY, Liang CS. Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure. Am J Physiol Heart Circ Physiol. 2000;278:H1708-H1716.
10. Rundqvist B, Eisenhofer G, Elam M, Friberg P. Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation. 1997;95:940-945.
11. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
12. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, MacMahon SB, Shelton DL, Levinson AD. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 1994;76:1001-1011.
13. Shelton DL, Reichardt LF. Expression of the beta-nerve growth factor gene correlates with the density of sympathetic innervation in effector organs. Proc Natl Acad Sci U S A. 1984;81:7951-7955.
14. Qin F, Vulapalli RS, Stevens SY, Liang CS. Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am J Physiol Heart Circ Physiol. 2002;282:H363-H371.
15. Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res. 2000;86:E80-E84.
16. Backs J, Bresch E, Lutz M, Kristen AV, Haass M. Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats. Cardiovasc Res. 2005;67:283-290.
17. Langendorff O. Untersuchungen am ueberlebenden Saeugetierherzen. Arch Ges Physiol. 1895;61:291-332.
18. Haass M, Cheng B, Richardt G, Lang RE, Schömig A. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn Schmiedebergs Arch Pharmacol Jan-. 1989;339:71-78.
19. Haass M, Richardt G, Brenn T, Schömig E, Schömig A. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: role of calcium channels and protein kinase C. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:527-531.
20. Kinscherf R, Kamencic H, Deigner HP, Pill J, Schmiedt W, Schrader M, Metz J. Effect of alterations of blood cholesterol levels on macrophages in the myocardium of New Zealand White rabbits. J Leukoc Biol. 1997;62:719-725.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Hardt SE, Geng YJ, Montagne O, Asai K, Hong C, Yang GP, Bishop SP, Kim SJ, Vatner DE, Seidman CE, Seidman JG, Homcy CJ, Vatner SF. Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain. Circulation. 2002;105:614-620.
23. Kiriazis H, Du XJ, Feng X, Hotchkin E, Marshall T, Finch S, Gao XM, Lambert G, Choate JK, Kaye DM. Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation. Am J Physiol Heart Circ Physiol. 2005;289:H1359-H1365.
24. Hassankhani A, Steinhelper ME, Soonpaa MH, Katz EB, Taylor DA, Andrade-Rozental A, Factor SM, Steinberg JJ, Field LJ, Federoff HJ. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol. 1995;169:309-321.
25. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen PS. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816-821.
26. Snider WD. Nerve growth factor enhances dendritic arborization of sympathetic ganglion cells in developing mammals. J Neurosci. 88;8:2628-2634.
27. Lockhart ST, Turrigiano GG, Birren SJ. Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci. 1997;17:9573-9582.
28. Dixon JE, McKinnon D. Expression of the trk gene family of neurotrophin receptors in prevertebral sympathetic ganglia. Brain Res Dev Brain Res. 1994;77:177-182.
29. Pardini BJ, Lund DD, Schmid PG. Innervation patterns of the middle cervical-stellate ganglion complex in the rat. Neurosci Lett. 1990;117:300-306.
30. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther. 1998;287:733-743.
31. Ieda M, Fukuda K, Hisaka Y, Kimura K, Kawaguchi H, Fujita J, Shimoda K, Takeshita E, Okano H, Kurihara Y, Kurihara H, Ishida J, Fukamizu A, Federoff HJ, Ogawa S. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest. 2004;113:876-884.
32. Badoyannis HC, Sharma SC, Sabban EL. The differential effects of cell density and NGF on the expression of tyrosine hydroxylase and dopamine beta-hydroxylase in PC12 cells. Brain Res Mol Brain Res. 1991;11:79-87.
33. Raynaud B, Faucon-Biguet N, Vidal S, Mallet J, Weber MJ. Regulation of neurotransmitter metabolic enzymes and tyrosine hydroxylase mRNA level by nerve growth factor in cultured sympathetic neurones. Development. 1988;102:361-368.
34. Ikeda J, Haneda T, Kanda H, Hiramoto T, Furuyama M, Sakuma T, Shirato K, Takishima T. Influence of reduced presynaptic myocardial norepinephrine stores on left ventricular contractility. J Auton Nerv Syst. 1991;34:231-238.
35. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169-175.
36. Ungerer M, Hartmann F, Karoglan M, Chlistalla A, Ziegler S, Richardt G, Overbeck M, Meisner H, Schomig A, Schwaiger M. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation. 1998;97:174-180.
37. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
38. Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, Hirata A, Asai M, Kusuoka H, Hori M, Hoki N. Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart. 2001;86:656-660.